Angela Hudson Davis, DrPH

Angela Hudson Davis, DrPH has a wealth of experience in Quality Assurance and Compliance. Angela began their career in 2001 as a Compliance Auditor at Bristol-Myers Squibb, where they were promoted to Compliance Manager and Senior Compliance Auditor. In 2011, they joined Boehringer Ingelheim as an Associate Director of Clinical Compliance, where they were responsible for improving business line strategy/execution within quality and regulatory channels. In 2017, they moved to Takeda as an Associate Director of Clinical Quality Assurance. In 2019, they became a Director at Sarepta Therapeutics and in 2020, they took on the role of Director of Inspection Management at Regeneron. Most recently, in 2022, they were appointed as the Head Quality Assurance and Compliance at Trevi Therapeutics, Inc.

Angela Hudson Davis, DrPH, obtained their Doctor of Public Health (Dr.PH) from Capella University in 2016, focusing on Public Health - Health Advocacy and Leadership. In 1997, they earned their MPH from Southern Connecticut State University in Public Health. Angela also obtained their Bachelor of Science - BS from Southern Connecticut State University in Corporate Communications in 1993. Additionally, they hold a Certification - Green Belt from Six Sigma.